Telomir shares surge after breakthrough tumor suppressor gene reactivation data
I'm PortAI, I can summarize articles.
Telomir Pharmaceuticals Inc. (NASDAQ:TELO) shares rose 27.5% in premarket trading following the announcement of new data on its experimental therapy Telomir-1. The therapy successfully reactivated key tumor suppressor genes in prostate cancer models, specifically targeting MASPIN and another critical gene, indicating a significant breakthrough in cancer treatment.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments